Leonardo Allegretta

Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients

Antonio Tursi, Giammarco Mocci, Roberto Lorenzetti et al. · European Journal of Gastroenterology & Hepatology · 2021 · 47 citations

Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study

Antonio Tursi, Giovanni Brandimarte, Francesco Di Mario et al. · Gut · 2021 · 32 citations

Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers

Antonio Tursi, Leonardo Allegretta, N. Buccianti et al. · Journal of Gastrointestinal and Liver Diseases · 2017 · 30 citations · Full text

Effectiveness and Safety of Pylera® in Patients Infected by <b><i>Helicobacter Pylori</i></b>: A Multicenter, Retrospective, Real Life Study

Antonio Tursi, Marilisa Franceschi, Leonardo Allegretta et al. · Digestive Diseases · 2018 · 25 citations

Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers

Antonio Tursi, Giammarco Mocci, Roberto Faggiani et al. · European Journal of Internal Medicine · 2019 · 25 citations

Real-life Treatment, Anti-inflammatory, Pharmacology +8